Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +28.50% per year, and are the best biotech stocks to buy now. Learn More.

Industry: Biotechnology

Value Growth Financials Momentum Sentiment Forecast Dividends Due Diligence

Biotech is Zen Rated F and is the 134th ranked industry out of 145 stock market industries

Ticker	Company	Price	1d %	1w %	1m %	3m %	6m %	1y %	3y %	5y %	10y %	52-week High	52-week Low	% off 52-week High	% off 52-week Low	Beta	Volume	Vol 1d %
DNLI	DENALI THERAPEUTICS INC	$18.74	-0.79%	-6.63%	1.85%	-24.50%	-5.35%	9.27%	15.68%	-62.61%	N/A	$27.30	$15.34	31.36%	22.16%	1.56	796,000	-39.24%
JANX	JANUX THERAPEUTICS INC	$11.37	-1.09%	-35.51%	-33.82%	-28.94%	-22.18%	-58.59%	60.37%	-46.37%	N/A	$35.34	$11.16	67.83%	1.93%	1.42	718,000	-38.58%
VRTX	VERTEX PHARMACEUTICALS INC	$538.60	-0.74%	-1.55%	11.00%	4.29%	18.88%	23.95%	42.14%	188.24%	470.43%	$568.67	$412.27	5.29%	30.64%	0.54	756,000	-23.17%
REPL	REPLIMUNE GROUP INC	$21.89	-0.41%	1.25%	80.76%	44.11%	313.02%	143.76%	104.20%	-33.75%	N/A	$23.54	$1.50	7.01%	1,359.33%	1.01	2,021,000	-30.12%
YARW	YARROW BIOSCIENCE INC	$18.03	-8.15%	15.58%	-3.06%	-57.79%	-46.18%	-2.36%	-89.64%	-98.43%	N/A	$46.95	$12.39	61.60%	45.58%	1.02	99,000	-26.67%
ANTX	AN2 THERAPEUTICS INC	$4.55	2.48%	13.75%	26.39%	-23.91%	5.57%	302.65%	-69.65%	N/A	N/A	$7.19	$1.00	36.72%	355.00%	0.80	206,000	10.75%
ALNY	ALNYLAM PHARMACEUTICALS INC	$165.04	5.36%	5.84%	-26.26%	-27.33%	-43.38%	-63.65%	0.02%	-4.77%	229.82%	$479.79	$149.18	65.60%	10.63%	0.86	3,590,000	2.13%
LXRX	LEXICON PHARMACEUTICALS INC	$1.79	-1.65%	0.56%	11.18%	-23.50%	-26.64%	24.31%	67.29%	-65.24%	-89.48%	$2.68	$1.10	33.21%	62.73%	1.37	1,892,000	12.22%
CYTK	CYTOKINETICS INC	$56.13	-0.05%	4.54%	-8.91%	-23.58%	-27.31%	-14.33%	75.35%	43.19%	398.93%	$88.31	$53.55	36.44%	4.82%	0.97	1,015,000	-49.48%
NRXS	NEURAXIS INC	$5.42	-5.74%	-13.14%	-16.62%	-13.69%	-31.48%	130.64%	123.97%	N/A	N/A	$9.33	$2.21	41.91%	145.25%	1.12	203,000	13.41%
BLTE	BELITE BIO INC	$164.36	-3.30%	6.59%	8.22%	-1.16%	7.06%	46.21%	318.21%	N/A	N/A	$200.00	$105.88	17.82%	55.23%	0.30	217,000	-56.34%
IVA	INVENTIVA SA	$3.68	-5.15%	-3.16%	28.22%	-20.00%	-33.57%	-3.66%	-0.92%	-72.94%	N/A	$7.29	$2.82	49.52%	30.50%	0.38	3,316,000	32.43%
PHAT	PHATHOM PHARMACEUTICALS INC	$6.06	-2.73%	15.43%	-13.43%	-33.99%	-51.75%	-59.19%	-15.24%	-71.91%	N/A	$18.31	$5.02	66.90%	20.84%	1.37	1,510,000	38.79%
OKUR	ONKURE THERAPEUTICS INC	$2.63	-12.62%	-8.20%	12.15%	-32.56%	-22.65%	-16.24%	-57.92%	-67.81%	N/A	$5.38	$2.01	51.12%	30.85%	0.76	891,000	210.45%
VCRE	VICORE PHARMA HOLDING AB	$10.36	-5.73%	-0.38%	15.75%	-15.77%	N/A	N/A	N/A	N/A	N/A	$17.80	$7.88	41.80%	31.47%	0.43	17,900	225.45%
RNAC	CARTESIAN THERAPEUTICS INC	$6.35	-0.08%	-15.67%	-3.35%	-27.18%	-24.58%	-12.17%	-75.98%	-94.10%	-99.10%	$11.00	$5.60	42.27%	13.39%	1.53	107,000	-59.62%
LYCA	LYCIA THERAPEUTICS INC	$31.20	-4.96%	2.30%	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$36.49	$22.19	14.50%	40.60%	0.13	189,000	-61.90%
ELOX	ELOXX PHARMACEUTICALS INC	$13.15	2.02%	5.71%	3.54%	-31.04%	819.58%	1,314,900.00%	1.31%	-97.57%	-99.07%	$23.40	$0.00	43.80%	1,314,900.00%	-104.78	14,800	335.29%
CELU	CELULARITY INC	$0.63	-8.03%	-17.11%	-55.63%	-9.35%	-19.95%	-60.38%	-71.23%	-99.07%	N/A	$2.55	$0.56	75.29%	12.50%	1.47	139,000	13.93%
INVA	INNOVIVA INC	$19.03	0.32%	-0.37%	-8.24%	-8.29%	-17.76%	-14.28%	39.52%	10.06%	70.37%	$25.15	$18.66	24.32%	1.98%	0.38	561,000	-0.53%
NBTX	NANOBIOTIX SA	$30.66	-4.95%	0.08%	42.65%	-19.69%	-41.09%	51.23%	430.36%	222.68%	N/A	$57.14	$19.14	46.35%	60.16%	1.05	93,000	-45.61%
LKFT	LAKEFRONT BIOTHERAPEUTICS NV	$33.98	0.15%	1.58%	16.97%	21.18%	20.75%	7.91%	-6.60%	-35.63%	-43.05%	$36.24	$25.68	6.24%	32.32%	0.57	288,000	-46.27%
MANE	VERADERMICS INC	$129.66	-4.16%	-6.57%	11.53%	16.81%	21.02%	N/A	N/A	N/A	N/A	$156.63	$32.00	17.22%	305.19%	1.17	938,000	-59.32%
RLMD	RELMADA THERAPEUTICS INC	$4.21	1.20%	7.95%	25.30%	-11.37%	-43.79%	8.51%	49.29%	-81.45%	8.51%	$8.00	$3.07	47.38%	37.13%	0.76	1,736,000	67.08%
IAM	IAMBIC THERAPEUTICS INC	$13.10	-11.73%	28.81%	-30.72%	N/A	N/A	N/A	N/A	N/A	N/A	$25.00	$9.60	47.60%	36.46%	3.05	277,000	-43.35%
ELVN	ENLIVEN THERAPEUTICS INC	$48.80	1.01%	-1.27%	23.58%	-15.95%	12.03%	140.75%	347.71%	239.83%	N/A	$62.32	$14.79	21.69%	230.06%	1.12	973,000	6.11%
IMCR	IMMUNOCORE HOLDINGS PLC	$29.94	-1.76%	-3.39%	7.62%	-12.46%	3.42%	-15.35%	-40.17%	-23.43%	N/A	$40.72	$27.50	26.46%	8.87%	0.77	270,000	-41.43%
DNA	GINKGO BIOWORKS HOLDINGS INC	$9.61	-6.06%	-14.88%	-18.28%	32.73%	11.87%	20.13%	-81.23%	-98.15%	N/A	$18.22	$5.37	47.26%	78.96%	2.55	1,860,000	-25.54%
XFOR	X4 PHARMACEUTICALS INC	$3.12	-1.58%	-1.89%	20.00%	-27.27%	-26.24%	-16.35%	-86.32%	-97.85%	N/A	$4.83	$2.43	35.40%	28.40%	1.31	501,000	-76.85%
PBM	PSYENCE BIOMEDICAL LTD	$3.15	1.78%	6.25%	-30.88%	-11.66%	-39.05%	-81.96%	-99.99%	-99.99%	N/A	$18.14	$1.92	82.66%	63.80%	0.71	43,300	-34.79%
IONS	IONIS PHARMACEUTICALS INC	$29.06	6.41%	-26.28%	-31.43%	-47.99%	-62.55%	-58.39%	-38.22%	-11.38%	-38.81%	$86.74	$27.25	66.50%	6.64%	0.73	5,823,000	-6.10%
ASPE	ASPEN NEUROSCIENCE INC	$12.59	-7.49%	1.21%	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$14.90	$11.20	15.50%	12.41%	1.93	173,000	-35.21%
SLGL	SOL-GEL TECHNOLOGIES LTD	$55.12	-2.01%	-9.65%	-19.30%	-34.41%	-24.54%	54.94%	277.53%	-38.21%	N/A	$97.97	$32.51	43.74%	69.55%	0.55	34,600	-23.11%
QSI	QUANTUM-SI INC	$1.15	-5.74%	-13.53%	-18.44%	45.57%	23.79%	-17.27%	-14.81%	-85.42%	N/A	$1.81	$0.69	36.46%	66.67%	2.31	3,586,000	-34.59%
PDSB	PDS BIOTECHNOLOGY CORP	$0.87	-10.92%	-29.02%	-45.44%	274.68%	-34.36%	3.31%	-83.39%	-92.00%	-99.63%	$1.79	$0.20	51.23%	347.69%	1.97	5,924,000	100.34%
MESO	MESOBLAST LTD	$13.27	1.30%	-7.01%	-4.53%	-19.53%	-9.91%	-11.06%	418.36%	-6.42%	32.44%	$21.50	$11.89	38.28%	11.61%	1.29	347,000	88.59%
KRRO	KORRO BIO INC	$13.61	-4.89%	-7.73%	54.48%	2.41%	21.52%	109.38%	-73.20%	-95.77%	N/A	$17.35	$5.20	21.57%	161.53%	1.35	79,000	-61.27%
LYEL	LYELL IMMUNOPHARMA INC	$14.30	-8.57%	-3.77%	90.41%	4.08%	-25.68%	-17.86%	-53.87%	-93.53%	N/A	$45.00	$7.20	68.22%	98.75%	1.62	237,000	80.92%
IBIO	IBIO INC	$0.73	-3.95%	-1.22%	-6.41%	-47.86%	-52.90%	-36.52%	-87.34%	-99.81%	-99.97%	$3.82	$0.69	80.89%	5.80%	1.30	463,000	54.85%
PRQR	PROQR THERAPEUTICS NV	$1.41	3.68%	4.44%	-4.73%	-23.78%	-17.06%	-34.72%	0.71%	-81.83%	-72.08%	$2.49	$1.20	43.26%	17.50%	1.10	569,000	-30.18%
OCGN	OCUGEN INC	$0.83	-5.26%	-10.49%	-6.44%	-38.67%	-43.67%	-33.23%	126.85%	-90.02%	-99.39%	$2.73	$0.69	69.61%	19.83%	2.03	16,649,000	168.36%
TSHA	TAYSHA GENE THERAPIES INC	$4.10	-2.61%	-5.31%	14.53%	-31.55%	-38.53%	2.24%	208.27%	-71.72%	N/A	$7.30	$3.46	43.84%	18.67%	1.83	2,475,000	-36.23%
CGEN	COMPUGEN LTD	$2.10	-0.94%	7.14%	6.06%	-12.86%	-26.32%	27.27%	296.23%	-61.47%	-68.89%	$3.24	$1.43	35.09%	46.85%	1.64	210,000	10.53%
ABEO	ABEONA THERAPEUTICS INC	$2.42	5.68%	-41.97%	-46.46%	-61.86%	-57.62%	-46.58%	-46.22%	-89.37%	-98.69%	$7.65	$2.09	68.37%	15.79%	0.88	3,176,000	31.40%
NAUT	NAUTILUS BIOTECHNOLOGY INC	$2.32	-2.52%	4.04%	13.17%	160.67%	-21.36%	22.75%	-23.93%	-56.72%	N/A	$4.31	$0.84	46.17%	175.86%	1.59	1,862,000	-43.88%
TARS	TARSUS PHARMACEUTICALS INC	$80.28	4.41%	17.03%	13.36%	16.55%	24.16%	10.69%	367.56%	214.08%	N/A	$91.53	$53.89	12.29%	48.97%	0.84	719,000	61.57%
GYRE	GYRE THERAPEUTICS INC	$4.31	0.23%	-9.45%	-35.77%	-34.10%	-40.80%	-46.66%	-52.11%	-82.79%	-97.26%	$9.14	$3.97	52.84%	8.56%	1.37	281,000	61.49%
SLS	SELLAS LIFE SCIENCES GROUP INC	$7.86	-2.12%	-6.65%	-36.66%	-36.41%	20.37%	438.36%	793.18%	5.22%	-99.85%	$15.88	$1.39	50.49%	465.47%	1.24	11,124,000	153.97%
CTY	CITY THERAPEUTICS INC	$18.10	-4.64%	-0.82%	-19.20%	N/A	N/A	N/A	N/A	N/A	N/A	$23.88	$15.81	24.20%	14.48%	-1.43	481,000	124.77%
RANI	RANI THERAPEUTICS HOLDINGS INC	$0.53	0.19%	-3.84%	-28.24%	-34.09%	-49.90%	-72.75%	-73.03%	-98.25%	N/A	$1.99	$0.50	73.55%	4.78%	1.38	521,000	-25.99%
CVM	CEL SCI CORP	$1.28	7.56%	-11.72%	-26.86%	-14.09%	6.67%	-81.84%	-98.26%	-99.63%	-99.41%	$7.80	$0.89	83.59%	43.82%	1.15	146,000	-2.67%
LONA	LEONABIO INC	$3.47	-6.97%	-21.40%	-46.03%	-55.91%	-66.38%	-26.09%	-77.76%	-97.79%	N/A	$14.21	$2.21	75.58%	57.01%	1.20	20,200	-20.78%
CLNN	CLENE INC	$3.92	-2.00%	-0.76%	15.63%	-6.44%	-39.69%	-46.30%	-58.24%	-96.75%	N/A	$10.84	$3.02	63.84%	30.02%	0.88	28,700	-73.67%
RTSN	RETENSION PHARMACEUTICALS INC	$12.27	0.16%	11.14%	5.50%	N/A	N/A	N/A	N/A	N/A	N/A	$18.64	$9.66	34.17%	27.02%	1.34	125,000	32.98%
EVAX	EVAXION A	$2.74	-1.08%	-8.67%	-0.72%	-14.67%	-34.13%	-52.01%	-92.04%	-99.12%	N/A	$6.92	$2.65	60.40%	3.40%	0.60	46,400	-31.36%
VRDN	VIRIDIAN THERAPEUTICS INC	$30.87	1.28%	8.35%	69.43%	40.38%	81.16%	8.35%	120.66%	61.29%	-57.04%	$34.29	$13.19	9.97%	134.04%	0.96	1,204,000	-38.29%
AURA	AURA BIOSCIENCES INC	$7.11	0.00%	8.38%	13.40%	-7.06%	-11.35%	28.57%	-8.26%	-65.65%	N/A	$9.54	$4.73	25.43%	50.32%	1.07	610,000	-39.42%
ZLAB	ZAI LAB LTD	$24.60	-5.53%	-3.45%	6.49%	-5.49%	20.18%	13.21%	-9.02%	-71.38%	N/A	$29.02	$15.96	15.23%	54.14%	1.17	1,224,000	42.49%
QTTB	Q32 BIO INC	$8.71	-1.25%	-5.84%	8.06%	-43.33%	46.63%	294.12%	-53.02%	-91.19%	N/A	$23.57	$1.91	63.05%	357.22%	0.98	244,000	-31.46%
ENLV	ENLIVEX LTD	$1.19	-4.42%	-6.30%	-66.50%	-95.60%	-99.32%	-99.50%	-99.72%	-99.94%	-99.99%	$434.40	$1.18	99.73%	0.85%	0.87	22,300	7.21%
SPTX	SEAPORT THERAPEUTICS INC	$19.98	-0.75%	-7.07%	24.25%	-15.73%	21.09%	N/A	N/A	N/A	N/A	$28.38	$14.85	29.60%	34.55%	0.76	347,000	51.53%
SLXN	SILEXION THERAPEUTICS CORP	$1.98	-25.56%	-43.19%	-53.13%	-82.07%	-98.50%	-99.71%	-100.00%	-100.00%	N/A	$777.12	$1.82	99.75%	8.73%	0.84	103,000	45.07%
CAMP	CAMP4 THERAPEUTICS CORP	$3.80	-7.09%	-6.40%	10.79%	-15.56%	-15.56%	-11.01%	N/A	N/A	N/A	$7.75	$2.90	50.97%	31.03%	1.33	46,000	-26.28%
RAPP	RAPPORT THERAPEUTICS INC	$26.15	1.16%	7.00%	-9.80%	-44.78%	-31.33%	6.00%	N/A	N/A	N/A	$52.93	$22.06	50.60%	18.53%	1.30	316,000	-44.37%
CAI	CARIS LIFE SCIENCES INC	$23.04	-3.84%	-8.68%	-21.98%	3.88%	56.84%	-5.19%	N/A	N/A	N/A	$36.50	$14.19	36.88%	62.37%	1.67	3,021,000	-15.43%
DFTX	DEFINIUM THERAPEUTICS INC	$32.08	-2.79%	-3.58%	-6.69%	-26.92%	45.75%	175.84%	1,220.16%	-8.99%	N/A	$49.70	$10.47	35.45%	206.55%	1.55	777,000	-35.41%
AVTX	AVALO THERAPEUTICS INC	$7.76	0.78%	11.98%	-35.39%	-60.10%	-60.91%	-47.32%	-64.47%	-99.88%	-99.94%	$24.27	$6.53	68.03%	18.84%	0.88	974,000	-67.11%
ABCL	ABCELLERA BIOLOGICS INC	$11.49	-1.12%	-3.28%	-8.88%	4.74%	140.88%	217.40%	188.69%	-29.90%	N/A	$15.02	$2.75	23.48%	318.58%	1.47	2,615,000	-17.12%
PYXS	PYXIS ONCOLOGY INC	$1.58	0.00%	-4.82%	-14.59%	-47.51%	-39.69%	-64.73%	1.28%	-86.90%	N/A	$5.55	$1.03	71.53%	53.40%	1.10	358,000	-64.31%
NTHI	NEONC TECHNOLOGIES HOLDINGS INC	$4.91	1.24%	40.69%	89.21%	52.96%	-9.41%	-45.32%	N/A	N/A	N/A	$11.38	$2.50	56.84%	96.32%	-0.09	252,000	-20.25%
CTMX	CYTOMX THERAPEUTICS INC	$2.04	0.00%	-6.85%	-12.26%	-39.10%	-46.17%	-47.15%	65.85%	-71.90%	-81.96%	$8.21	$1.90	75.15%	7.37%	1.36	2,725,000	-13.68%
INO	INOVIO PHARMACEUTICALS INC	$1.43	-2.05%	17.70%	43.00%	58.89%	6.72%	-26.67%	-65.95%	-98.38%	-98.57%	$2.72	$0.57	47.43%	152.20%	1.48	5,180,000	-34.66%
BBOT	BRIDGEBIO ONCOLOGY THERAPEUTICS INC	$2.14	-8.94%	4.90%	-27.46%	-76.81%	-73.51%	-82.71%	N/A	N/A	N/A	$14.87	$1.98	85.61%	8.08%	0.52	677,000	-13.09%
SANA	SANA BIOTECHNOLOGY INC	$2.02	0.50%	-14.77%	-16.18%	-44.96%	-36.88%	-44.81%	-41.95%	-90.58%	N/A	$5.49	$1.86	63.21%	8.60%	2.11	3,201,000	-13.18%
IRON	DISC MEDICINE INC	$80.00	-3.88%	1.38%	41.34%	-0.01%	14.24%	-8.09%	61.32%	123.46%	N/A	$99.50	$40.00	19.60%	100.00%	0.92	780,000	2.50%
NAGE	NIAGEN BIOSCIENCE INC	$2.07	-3.27%	0.00%	-19.77%	-32.13%	-44.95%	-70.39%	52.21%	-66.23%	-28.13%	$7.12	$2.04	70.93%	1.72%	1.54	315,000	-38.83%
EDIT	EDITAS MEDICINE INC	$2.17	1.40%	-15.56%	-11.25%	-22.78%	-25.17%	-14.57%	-71.63%	-93.97%	-87.24%	$3.94	$1.66	44.92%	30.72%	2.09	2,792,000	-28.17%
LGND	LIGAND PHARMACEUTICALS INC	$308.79	-2.37%	0.85%	1.73%	6.91%	39.59%	53.42%	459.71%	88.16%	182.13%	$326.63	$175.89	5.46%	75.56%	1.11	131,000	-46.96%
SCTX	SCRIBE THERAPEUTICS INC	$16.36	-3.71%	4.20%	-14.44%	-19.69%	N/A	N/A	N/A	N/A	N/A	$39.60	$13.50	58.69%	21.19%	1.11	331,000	17.38%
TRAX	FIRST TRACKS BIOTHERAPEUTICS INC	$47.10	-3.29%	-1.67%	48.67%	6.97%	155.56%	N/A	N/A	N/A	N/A	$54.78	$14.88	14.02%	216.53%	2.09	462,000	48.55%
KURA	KURA ONCOLOGY INC	$7.77	4.58%	6.88%	-20.96%	-22.99%	-18.04%	-27.25%	-10.69%	-55.50%	42.57%	$13.90	$6.75	44.10%	15.11%	1.08	2,227,000	-21.72%
DTIL	PRECISION BIOSCIENCES INC	$7.57	-5.91%	-28.63%	24.02%	3.63%	-9.29%	29.32%	-26.48%	-97.34%	N/A	$11.29	$3.53	32.99%	114.31%	1.15	395,000	-4.59%
ONCO	ONCONETIX INC	$3.21	5.94%	-53.81%	-42.16%	-63.62%	-91.71%	-99.74%	-100.00%	N/A	N/A	$1.61k	$2.91	99.80%	10.31%	0.81	70,000	-22.65%
QURE	UNIQURE NV	$23.81	-3.33%	9.72%	11.89%	-49.41%	-18.38%	-21.52%	296.83%	-23.39%	186.87%	$51.72	$8.73	53.96%	172.74%	1.30	1,395,000	-34.60%
AUTL	AUTOLUS THERAPEUTICS PLC	$1.17	-1.68%	-8.59%	-27.78%	-47.30%	-31.58%	-8.59%	-68.03%	-82.77%	N/A	$2.58	$1.12	54.65%	4.46%	1.16	1,796,000	-30.20%
IMVT	IMMUNOVANT INC	$34.18	-2.48%	11.96%	19.05%	-18.27%	16.85%	49.78%	4.21%	317.85%	N/A	$45.35	$21.86	24.63%	56.36%	1.13	865,000	-26.88%
VRXA	VERAXA BIOTECH AG	$1.11	-3.48%	16.84%	-7.50%	-41.27%	-89.56%	-89.43%	N/A	N/A	N/A	$27.36	$0.90	95.94%	23.33%	0.35	114,000	7.55%
ETRA	ELECTRA THERAPEUTICS INC	$8.84	-2.96%	13.33%	2.67%	N/A	N/A	N/A	N/A	N/A	N/A	$15.50	$6.87	42.97%	28.77%	2.14	313,000	-42.57%
AVBP	ARRIVENT BIOPHARMA INC	$13.01	-0.46%	-4.62%	-19.14%	-56.63%	-55.03%	-33.89%	N/A	N/A	N/A	$35.83	$11.36	63.69%	14.52%	0.89	616,000	-22.42%
FULC	FULCRUM THERAPEUTICS INC	$3.77	2.45%	1.89%	2.45%	1.62%	-48.00%	-57.11%	8.65%	-78.89%	N/A	$15.74	$2.91	76.05%	29.55%	1.26	1,364,000	-36.23%
ACOG	ALPHA COGNITION INC	$8.30	-3.04%	0.12%	-5.68%	-3.82%	39.50%	35.40%	N/A	N/A	N/A	$10.14	$4.50	18.15%	84.44%	0.96	87,000	-37.41%
ABSI	ABSCI CORP	$8.45	-7.50%	-16.91%	-7.14%	-10.68%	59.43%	220.08%	576.00%	-25.42%	N/A	$12.55	$2.24	32.64%	277.23%	2.24	5,472,000	11.26%
HYFT	MINDWALK HOLDINGS CORP	$0.99	-1.00%	-6.60%	-33.11%	-28.78%	-21.43%	-40.00%	-36.13%	-83.77%	N/A	$2.95	$0.91	66.44%	8.67%	1.06	349,000	56.50%
GALT	GALECTIN THERAPEUTICS INC	$3.05	-2.87%	-2.87%	-17.34%	-13.60%	36.77%	-44.85%	56.41%	6.64%	193.27%	$7.13	$2.03	57.22%	50.62%	0.80	182,000	-19.47%
COAG	HEMAB THERAPEUTICS HOLDINGS INC	$40.86	3.76%	-16.65%	37.11%	-24.26%	43.07%	N/A	N/A	N/A	N/A	$55.42	$23.00	26.27%	77.65%	0.74	401,000	-5.87%
ARVN	ARVINAS INC	$6.82	-0.73%	6.40%	-0.29%	-24.31%	-30.90%	-32.61%	-58.89%	-91.78%	N/A	$14.51	$6.33	53.00%	7.74%	1.38	879,000	-4.87%
PRME	PRIME MEDICINE INC	$4.27	9.77%	-8.17%	28.61%	34.70%	30.58%	28.23%	-35.93%	N/A	N/A	$5.91	$2.67	27.75%	59.93%	1.99	5,953,000	-17.01%
CNXU	CONEXEU SCIENCES INC	$2.18	0.00%	-3.54%	-34.14%	-72.65%	N/A	N/A	N/A	N/A	N/A	$18.79	$1.93	88.40%	13.01%	1.48	193,000	28.67%
CDXS	CODEXIS INC	$1.16	20.83%	7.41%	-12.12%	-27.50%	-53.60%	-28.83%	-30.12%	-96.80%	-76.57%	$2.98	$0.90	61.07%	28.89%	1.95	2,500,000	145.10%
BRVE	BRAVEHEART BIO INC	$19.62	-4.29%	5.48%	1.50%	-24.45%	N/A	N/A	N/A	N/A	N/A	$32.00	$16.70	38.69%	17.49%	1.17	537,000	109.77%

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in Nov 2026?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best biotechnology stocks to buy right now are:

1. Xeris Biopharma Holdings (NASDAQ:XERS)

Xeris Biopharma Holdings (NASDAQ:XERS) is the #1 top biotech stock out of 607 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Xeris Biopharma Holdings (NASDAQ:XERS) is: Value: C, Growth: A, Momentum: A, Sentiment: A, Safety: C, Financials: B, and AI: B.

Xeris Biopharma Holdings (NASDAQ:XERS) has a Due Diligence Score of 39, which is 15 points higher than the biotech industry average of 24.

XERS passed 13 out of 33 due diligence checks and has average fundamentals. Xeris Biopharma Holdings has seen its stock return 129.48% over the past year, overperforming other biotech stocks by 225 percentage points.

Xeris Biopharma Holdings has an average 1 year price target of $17.00, an upside of 2.04% from Xeris Biopharma Holdings's current stock price of $16.66.

Xeris Biopharma Holdings stock has a consensus Buy recommendation according to Wall Street analysts. Of the 5 analysts covering Xeris Biopharma Holdings, 20% have issued a Strong Buy rating, 60% have issued a Buy, 20% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Regeneron Pharmaceuticals (NASDAQ:REGN)

Regeneron Pharmaceuticals (NASDAQ:REGN) is the #2 top biotech stock out of 607 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Regeneron Pharmaceuticals (NASDAQ:REGN) is: Value: B, Growth: B, Momentum: B, Sentiment: A, Safety: B, Financials: B, and AI: B.

Regeneron Pharmaceuticals (NASDAQ:REGN) has a Due Diligence Score of 47, which is 23 points higher than the biotech industry average of 24.

REGN passed 18 out of 38 due diligence checks and has strong fundamentals. Regeneron Pharmaceuticals has seen its stock return 37.48% over the past year, overperforming other biotech stocks by 133 percentage points.

Regeneron Pharmaceuticals has an average 1 year price target of $904.29, a downside of -5.36% from Regeneron Pharmaceuticals's current stock price of $955.47.

Regeneron Pharmaceuticals stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 24 analysts covering Regeneron Pharmaceuticals, 58.33% have issued a Strong Buy rating, 8.33% have issued a Buy, 33.33% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Fennec Pharmaceuticals (NASDAQ:FENC)

Fennec Pharmaceuticals (NASDAQ:FENC) is the #3 top biotech stock out of 607 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Fennec Pharmaceuticals (NASDAQ:FENC) is: Value: C, Growth: B, Momentum: C, Sentiment: A, Safety: C, Financials: A, and AI: C.

Fennec Pharmaceuticals (NASDAQ:FENC) has a Due Diligence Score of 50, which is 26 points higher than the biotech industry average of 24.

FENC passed 17 out of 33 due diligence checks and has strong fundamentals. Fennec Pharmaceuticals has seen its stock return 51.11% over the past year, overperforming other biotech stocks by 147 percentage points.

Fennec Pharmaceuticals has an average 1 year price target of $16.67, an upside of 43.43% from Fennec Pharmaceuticals's current stock price of $11.62.

Fennec Pharmaceuticals stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Fennec Pharmaceuticals, 33.33% have issued a Strong Buy rating, 66.67% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 8 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Rallybio (NASDAQ:RLYB)

Rallybio (NASDAQ:RLYB) has an annual dividend yield of 86.26%, which is 73 percentage points higher than the biotech industry average of 12.82%.

Rallybio's dividend payout ratio of 0% indicates that its high dividend yield might not be sustainable for the long-term.

2. Oramed Pharmaceuticals (NASDAQ:ORMP)

Oramed Pharmaceuticals (NASDAQ:ORMP) has an annual dividend yield of 6.74%, which is -6 percentage points lower than the biotech industry average of 12.82%.

Oramed Pharmaceuticals's dividend payout ratio of 7.1% indicates that its high dividend yield is sustainable for the long-term.

3. Novo Nordisk (Ozempic) (NYSE:NVO)

Novo Nordisk (Ozempic) (NYSE:NVO) has an annual dividend yield of 4.45%, which is -8 percentage points lower than the biotech industry average of 12.82%. Novo Nordisk (Ozempic)'s dividend payout is not stable, having dropped more than 10% nine times in the last 10 years. Novo Nordisk (Ozempic)'s dividend has shown consistent growth over the last 10 years.

Novo Nordisk (Ozempic)'s dividend payout ratio of 48.3% indicates that its high dividend yield is sustainable for the long-term.

Why are biotech stocks down?

Biotech stocks were down -0.68% in the last day, and up 0.7% over the last week. Oragenics was the among the top losers in the biotechnology industry, dropping -42.86% yesterday.

Oragenics shares are trading lower. The stock initially rallied yesterday after the company announced it had been granted an extension to regain NYSE compliance, but it has since reversed.

What are the most undervalued biotech stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued biotech stocks right now are:

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 57, which is 42 points higher than the biotech industry average of 15. It passed 4 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has dropped -1.55% in the past year. It has overperformed other stocks in the biotech industry by 94 percentage points.

2. Innoviva (NASDAQ:INVA)

Innoviva (NASDAQ:INVA) is the second most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Innoviva has a valuation score of 43, which is 28 points higher than the biotech industry average of 15. It passed 3 out of 7 valuation due diligence checks.

Innoviva's stock has dropped -14.28% in the past year. It has overperformed other stocks in the biotech industry by 81 percentage points.

3. Zevra Therapeutics (NASDAQ:ZVRA)

Zevra Therapeutics (NASDAQ:ZVRA) is the third most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Zevra Therapeutics has a valuation score of 43, which is 28 points higher than the biotech industry average of 15. It passed 3 out of 7 valuation due diligence checks.

Zevra Therapeutics's stock has dropped -1.63% in the past year. It has overperformed other stocks in the biotech industry by 94 percentage points.

Are biotech stocks a good buy now?

62.71% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 79.98% over the next year.

2.25% of biotech stocks have a Zen Rating of A (Strong Buy), 3.83% of biotech stocks are rated B (Buy), 44.82% are rated C (Hold), 36.71% are rated D (Sell), and 12.39% are rated F (Strong Sell).

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is 18.56x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +28.50% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Xeris Biopharma Holdings (NASDAQ:XERS)

2. Regeneron Pharmaceuticals (NASDAQ:REGN)

3. Fennec Pharmaceuticals (NASDAQ:FENC)

1. Rallybio (NASDAQ:RLYB)

2. Oramed Pharmaceuticals (NASDAQ:ORMP)

3. Novo Nordisk (Ozempic) (NYSE:NVO)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Innoviva (NASDAQ:INVA)

3. Zevra Therapeutics (NASDAQ:ZVRA)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBiotechnologyBest Biotech Stocks to Buy Now (2026)Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +28.50% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Xeris Biopharma Holdings (NASDAQ:XERS)

2. Regeneron Pharmaceuticals (NASDAQ:REGN)

3. Fennec Pharmaceuticals (NASDAQ:FENC)

1. Rallybio (NASDAQ:RLYB)

2. Oramed Pharmaceuticals (NASDAQ:ORMP)

3. Novo Nordisk (Ozempic) (NYSE:NVO)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Innoviva (NASDAQ:INVA)

3. Zevra Therapeutics (NASDAQ:ZVRA)

Company

Stock Tools

Stock Ideas

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +28.50% per year, and are the best biotech stocks to buy now. Learn More.